
Dr. Raje discusses results from a large phase III trial comparing denosumab with zoledronic acid for delaying the time to a skeletal-related complication in patients with myeloma.
Dr. Raje discusses results from a large phase III trial comparing denosumab with zoledronic acid for delaying the time to a skeletal-related complication in patients with myeloma.